TickerFactsScreenerDevelopers

KYNTRA BIO, INC. (KYNB) — Cash & Equivalents

Annual figures by fiscal year, from SEC filings.

2012: $38.87M2013: $76.33M2014: $165.46M2015: $153.32M2016: $173.78M2017: $673.66M2018: $89.26M2019: $126.27M2020: $678.39M2021: $171.22M2022: $155.70M2023: $81.55M2024: $50.48M2025: $47.87M$47.87M
2012Cash & Equivalents (USD)2025
Fiscal YearCash & EquivalentsChange YoY
2025$47.87M-5.2%
2024$50.48M-38.1%
2023$81.55M-47.6%
2022$155.70M-9.1%
2021$171.22M-74.8%
2020$678.39M+437.3%
2019$126.27M+41.5%
2018$89.26M-86.8%
2017$673.66M+287.6%
2016$173.78M+13.3%
2015$153.32M-7.3%
2014$165.46M+116.8%
2013$76.33M+96.4%
2012$38.87M—